Zhejiang Jingxin Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Jingxin Pharmaceutical Co Ltd financial flexibility index. Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of CN¥263.19 Million (operating CF CN¥227.64 Million minus capex CN¥35.55 Million) represents 0% of total liabilities (CN¥2.29 Billion). See Zhejiang Jingxin Pharmaceutical Co Ltd (002020) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Financial flexibility index of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. Historical Financial Flexibility Index trend for Zhejiang Jingxin Pharmaceutical Co Ltd across 24 annual periods. Check Zhejiang Jingxin Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Jingxin Pharmaceutical Co Ltd Financial Flexibility Index by Year (2002–2025)
Zhejiang Jingxin Pharmaceutical Co Ltd financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Jingxin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥984.20 Million | CN¥781.35 Million | CN¥2.25 Billion | ▲ +10.8% |
| 2024 | 0.39x | CN¥976.81 Million | CN¥726.16 Million | CN¥2.48 Billion | ▼ -28.3% |
| 2023 | 0.55x | CN¥1.34 Billion | CN¥824.69 Million | CN¥2.45 Billion | ▼ -12.2% |
| 2022 | 0.63x | CN¥1.37 Billion | CN¥855.78 Million | CN¥2.19 Billion | ▲ +28.4% |
| 2021 | 0.49x | CN¥769.46 Million | CN¥365.02 Million | CN¥1.58 Billion | ▼ -0.2% |
| 2020 | 0.49x | CN¥847.21 Million | CN¥513.21 Million | CN¥1.73 Billion | ▲ +7.2% |
| 2019 | 0.46x | CN¥872.64 Million | CN¥535.30 Million | CN¥1.91 Billion | ▼ -15.6% |
| 2018 | 0.54x | CN¥765.60 Million | CN¥523.40 Million | CN¥1.42 Billion | ▲ +1.9% |
| 2017 | 0.53x | CN¥497.20 Million | CN¥385.01 Million | CN¥938.43 Million | ▲ +31.6% |
| 2016 | 0.40x | CN¥347.96 Million | CN¥252.69 Million | CN¥864.23 Million | ▲ +5.6% |
| 2015 | 0.38x | CN¥259.00 Million | CN¥144.69 Million | CN¥679.39 Million | ▼ -16.8% |
| 2014 | 0.46x | CN¥305.23 Million | CN¥210.49 Million | CN¥666.12 Million | ▲ +5.9% |
| 2013 | 0.43x | CN¥219.31 Million | CN¥111.03 Million | CN¥506.65 Million | ▲ +59.1% |
| 2012 | 0.27x | CN¥143.79 Million | CN¥60.28 Million | CN¥528.40 Million | ▼ -17.9% |
| 2011 | 0.33x | CN¥141.27 Million | CN¥69.41 Million | CN¥426.39 Million | ▼ -3.3% |
| 2010 | 0.34x | CN¥215.42 Million | CN¥59.55 Million | CN¥629.02 Million | ▲ +34.3% |
| 2009 | 0.25x | CN¥155.56 Million | CN¥135.38 Million | CN¥610.06 Million | ▲ +124.6% |
| 2008 | 0.11x | CN¥73.80 Million | CN¥29.98 Million | CN¥649.89 Million | ▲ +348.3% |
| 2007 | -0.05x | CN¥-32.75 Million | CN¥-87.60 Million | CN¥716.18 Million | ▼ -124.3% |
| 2006 | 0.19x | CN¥89.86 Million | CN¥-1.45 Million | CN¥478.23 Million | ▼ -73.3% |
| 2005 | 0.70x | CN¥196.49 Million | CN¥61.82 Million | CN¥279.27 Million | ▲ +21.9% |
| 2004 | 0.58x | CN¥104.54 Million | CN¥6.43 Million | CN¥181.11 Million | ▼ -16.2% |
| 2003 | 0.69x | CN¥117.37 Million | CN¥46.18 Million | CN¥170.36 Million | ▼ -11.9% |
| 2002 | 0.78x | CN¥93.29 Million | CN¥45.50 Million | CN¥119.35 Million | — |